|
CIVIL DOCKET |
UPDATED CIVIL DOCKET |
Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:16-cv-00999-LPS, 1:16-cv-01000-LPS, 1:16-cv-01001-LPS, 1:16-cv-01011-LPS, 1:16-cv-01012-LPS and 1:16-cv-01013-LPS (rjb) (Entered: 11/02/2016) |
COMPLAINT for PATENT INFRINGEMENT filed against MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2020178.) - filed by Onyx Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jcs) (Entered: 10/27/2016) |
MOTION for Pro Hac Vice Appearance of Attorney Robert S. Silver, Lynn Terrebonne, Salvatore Guerriero and Pei-Ru Wey - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Attachments: # 1 Certification of Robert S. Silver, # 2 Certification of Lynn Terrebonne, # 3 Certification of Salvatore Guerriero, # 4 Certification of Pei-Ru Wey)(Myer, R.) (Entered: 11/17/2016) |
PROPOSED ORDER -- Scheduling Order -- by Onyx Therapeutics, Inc.. (Attachments: # 1 Letter to The Honorable Leonard P. Stark)(Noreika, Maryellen) (Entered: 03/29/2017) |
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 10/27/2016) |
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/13/2016. Date of Expiration of Patent: 12/07/2027.Thirty Month Stay Deadline: 01/20/2020. (jcs) (Entered: 10/27/2016) |
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,737,112 B2. (jcs) (Entered: 10/27/2016) |
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen, Inc., Corporate Parent Onyx Pharmaceuticals Inc. for Onyx Therapeutics, Inc. filed by Onyx Therapeutics, Inc. (jcs) (Entered: 10/27/2016) |
SUMMONS Returned Executed by Onyx Therapeutics, Inc.. MSN Pharmaceuticals, Inc. served on 10/27/2016, answer due 11/17/2016. (Blumenfeld, Jack) (Entered: 10/27/2016) |
SUMMONS Returned Executed by Onyx Therapeutics, Inc.. MSN Laboratories Private Limited served on 10/27/2016, answer due 11/17/2016. (Noreika, Maryellen) (Entered: 10/28/2016) |
ANSWER to 1 Complaint, , COUNTERCLAIM against Onyx Therapeutics, Inc. by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Myer, R.) (Entered: 11/17/2016) |
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by MSN Laboratories Private Limited. (Myer, R.) (Entered: 11/17/2016) |
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals, Inc. filed by MSN Pharmaceuticals, Inc.. (Myer, R.) (Entered: 11/17/2016) |
MOTION for Pro Hac Vice Appearance of Attorney Wendy A. Whiteford, Erica S. Olson, and Brian Kao - filed by Onyx Therapeutics, Inc.. (Noreika, Maryellen) (Entered: 12/05/2016) |
NOTICE of Appearance (Lisa B. Pensabene) by Onyx Therapeutics, Inc. (Noreika, Maryellen) (Entered: 12/07/2016) |
MOTION for Pro Hac Vice Appearance of Attorney Filko Prugo, Margaret OBoyle, Carolyn S. Wall, Eberle Schultz, and Jenny Liu - filed by Onyx Therapeutics, Inc.. (Noreika, Maryellen) (Entered: 12/07/2016) |
ANSWER to 8 Answer to Complaint, Counterclaim by Onyx Therapeutics, Inc..(Noreika, Maryellen) (Entered: 12/08/2016) |
STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to March 29, 2017 - filed by Onyx Therapeutics, Inc.. (Noreika, Maryellen) (Entered: 03/22/2017) |
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These actions are consolidated for purposes of discovery and all papers shall be filed in Civil Action No. 16-988-LPS. Discovery due by 4/20/2018. Status Report due by 4/20/2018. Claim Construction Opening Brief due by 1/24/2018. Claim Construction Answering Brief due by 2/21/2018. A Markman Hearing is set for 3/26/2018 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 2/19/2019. A Final Pretrial Conference is set for 3/1/2019 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 9-day Bench Trial is set for 3/11/2019 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 4/18/17. Associated Cases: 1:16-cv-00988-LPS et al. (ntl) (Entered: 04/18/2017) |
ANSWER to 8 Answer to Complaint, Counterclaim /Answer to MSNs Counterclaims by Onyx Therapeutics, Inc..(Noreika, Maryellen) (Entered: 01/26/2018) |
STIPULATION re Withdrawal of Counterclaims by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., MSN Pharmaceuticals Inc.. (Myer, R.) (Entered: 05/07/2019) |
PROPOSED CONSENT JUDGMENT with Defendants MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited by Onyx Therapeutics, Inc.. (Dellinger, Megan) (Entered: 05/07/2019) |
CONSENT JUDGMENT re MSN, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 5/7/19. Associated Cases: 1:16-cv-00999-LPS, 1:17-cv-01833-LPS (ntl) (Entered: 05/08/2019) |